Journal article
Novel targets and approaches in advanced prostate cancer
Abstract
PURPOSE OF REVIEW: The development of therapeutic resistance is the underlying cause for most cancer deaths. By understanding the molecular basis of resistance to androgen withdrawal and chemotherapy in prostate cancer, the rational design of targeted therapeutics is possible. We review new treatment options for men with advanced prostate cancer.
RECENT FINDINGS: Although the taxanes currently represent the most active chemotherapeutic agents …
Authors
Hadaschik BA; Sowery RD; Gleave ME
Journal
Current Opinion in Urology, Vol. 17, No. 3, pp. 182–187
Publisher
Wolters Kluwer
Publication Date
May 2007
DOI
10.1097/mou.0b013e3280dd8a4f
ISSN
0963-0643